Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v2.4.0.6
Consolidated Statements of Operations (USD $)
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Revenue:    
Product revenues $ 26,000 $ 11,000
License revenues      
TOTAL REVENUE 26,000 11,000
Cost of Product Revenue 48,000 65,000
Gross profit (loss) (22,000) (54,000)
Operating Expenses:    
Research and development 17,000 179,000
Selling expenses 420,000   
Selling, general and administrative 3,469,000 2,264,000
Total operating expenses 3,906,000 2,443,000
Loss from Operations (3,928,000) (2,497,000)
Change in value of warrant and derivative liabilities 784,000 15,000
Interest expense/income (556,000) (513,000)
Total Other Income (Expense) 228,000 (498,000)
Loss before provision for income taxes (3,700,000) (2,995,000)
Provision for income taxes      
Net loss (3,700,000) (2,995,000)
Deemed dividends    23,000
Net loss attributable to common shareholders $ (3,700,000) $ (3,018,000)
Loss Per Share - basic and diluted $ (0.02) $ (0.03)
Weighted Average Shares Outstanding - basic and diluted 201,099,910 109,374,295